Next-Gen Biosafety Masterclass

11 Rue Watt, BioPark, Bâtiment B, 75013 Paris, France

PathoQuest is pleased to announce the upcoming Next-Gen Biosafety Masterclass:

"Next Generation Sequencing (NGS) in Biosafety Testing: From Regulation to Routine Use"


🕣 Registration: 08:30–09:00 CEST
🗣️ Presentations: 09:00–17:00 CEST
🍸 Networking Cocktail Reception: 17:00–18:00 CEST


Join us for a full day of expert presentations and discussions. Explore the agenda below:

Welcome & Strategic Context
Colette Côté – Executive Director & Scientific Advisor, Global Biologics Testing Services, PathoQuest
Horst Ruppach – Executive Director, Scientific & Portfolio, Global Biologics, Charles River Laboratories

Biologics: Market Trends, Pipeline Dynamics, and Industrial Production
Elsa Kress – Head of Business Development, MabDesign

European Regulations on the Detection of Viral Adventitious Agents Using Next Generation Sequencing (NGS)
Johannes Bluemel – Head of the Viral Safety Section, Paul-Ehrlich-Institut

Global Overview of the Implementation and Regulatory Acceptance of NGS for Vaccine Safety Testing
Laura Viviani – Founder and Consultant, SciEthiQ

Characterization of Starting Materials for the Production of Viral Therapeutics Using Next Generation Sequencing (NGS)
Michael Ruffing – Global Development CMC Biologicals, Boehringer Ingelheim

Integrated Use of Viromic and Transcriptomic NGS for Adventitious Virus Testing
Jens Modrof – Director of Operations, Global Pathogen Safety, Takeda

Agency Expectations and the Use of NGS: Have They Finally Aligned?
Colette Côté – Executive Director & Scientific Advisor, Global Biologics Testing Services, PathoQuest
Horst Ruppach – Executive Director, Scientific & Portfolio, Global Biologics, Charles River Laboratories

The Power and Challenges of NGS in Viral Vector Identity Assays
Nadia Avenier – Head of the Analytical Expertise Center, Yposkesi / an SK pharmteco company

Industry Presentation – Title to Be Confirmed (TBC)
Carine Logvinoff – Global Analytical Virology Expert, Sanofi

Adoption of NGS for Viral Safety Testing in Exosome Manufacturing
Huilan Lin – Principal Scientist, Capricor Therapeutics

Ask the Experts – Interactive Session
All Speakers

Closing Remarks & Networking Cocktail
Colette Côté – Executive Director & Scientific Advisor, Global Biologics Testing Services, PathoQuest

Upcoming events